Trial Profile
A monocenter retrospective study assessing tolerability, efficacy and retention rate of Brivaracetam in patients previously treated with Levetiracetam
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2018
Price :
$35
*
At a glance
- Drugs Brivaracetam (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 04 Dec 2018 New trial record